There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Phenylketonuria (PKU) is a genetic disease caused by mutations in human phenylalanine
hydroxylase (PAH). Most missense mutations result in misfolding of PAH, increased
protein turnover, and a loss of enzymatic function. We studied the prediction of the
energetic impact on PAH native-state stability of 318 PKU-associated missense mutations,
using the protein-design algorithm FoldX. For the 80 mutations for which expression
analyses have been performed in eukaryote systems, in most cases we found substantial
overall correlations between the mutational energetic impact and both in vitro residual
activities and patient metabolic phenotype. This finding confirmed that the decrease
in protein stability is the main molecular pathogenic mechanism in PKU and the determinant
for phenotypic outcome. Metabolic phenotypes have been shown to be better predicted
than in vitro residual activities, probably because of greater stringency in the phenotyping
process. Finally, all the remaining 238 PKU missense mutations compiled at the PAH
locus knowledgebase (PAHdb) were analyzed, and their phenotypic outcomes were predicted
on the basis of the energetic impact provided by FoldX. Residues in exons 7-9 and
in interdomain regions within the subunit appear to play an important structural role
and constitute hotspots for destabilization. FoldX analysis will be useful for predicting
the phenotype associated with rare or new mutations detected in patients with PKU.
However, additional factors must be considered that may contribute to the patient
phenotype, such as possible effects on catalysis and interindividual differences in
physiological and metabolic processes.